About: BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 24 May 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована в травні 2016 (uk) مقالة علمية نشرت في 24 مايو 2016 (ar) scientific article published on 24 May 2016 (en) artículu científicu espublizáu en mayu de 2016 (ast)
publication date	wds:Q37090142-692CF164-4329-40D8-8E27-807F5A71778B
publication date	2016-05-24 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37090142-61CD068F-5478-4A08-B932-1AC6A0D69787
language of work or name	English
cites work	wds:Q37090142-1236858D-E825-4C7D-BC9A-CDFFBD1B9590 wds:Q37090142-1746CA11-7B63-4013-B129-A3E8ADC2C6B5 wds:Q37090142-414B021A-1494-4234-9388-B4B201AF33CB wds:Q37090142-47BCF9C9-CF76-4029-A761-FA90AC8D1642 wds:Q37090142-508DB348-5417-4054-8409-D37635F72CF6 wds:Q37090142-5BA68E28-1542-4A56-AC99-0DC44FA08635 wds:Q37090142-6ABE69EF-EDF9-4A85-812F-3C89E3B7848E wds:Q37090142-6D6D4E6C-DFB9-437F-9F19-F0E1F39351FE wds:Q37090142-6F9EF8FB-0CFB-4BFB-879F-463E83CD77E1 wds:Q37090142-816E4941-3566-415F-AD9B-5DC4E78ED780 wds:Q37090142-901619D1-CC66-423F-9175-D63BC928C6D9 wds:Q37090142-9127CB01-CC32-4583-B65C-C3A60154C8B4 wds:Q37090142-98C79FC0-92CF-4C44-A1F8-B7D26FD417D9 wds:Q37090142-A398A893-25FA-4CBE-B8B4-3864856E4E23 wds:Q37090142-AE6C7E6B-76FB-4CE7-A5AB-50FA6CF07469 wds:Q37090142-B658DA2F-92EC-4268-8A3C-55B7D3C70414 wds:Q37090142-BFF705A5-F065-4749-8A8F-AC467BAA51A8 wds:Q37090142-C0D0F5D3-EC19-423C-8E3C-C30E78271800 wds:Q37090142-C4B022E1-C4D3-4332-8BAC-7A9D5BA54AE2 wds:Q37090142-CF7262F4-410D-41C9-A8D4-979FD646176A wds:Q37090142-D902CA4B-D50C-4FF4-A921-4ACB33C7793A wds:Q37090142-E060E8DC-C51F-4402-ACEF-AECEA517EA96 wds:Q37090142-E167635D-82D0-4CE3-837F-03CE860C9B5E wds:Q37090142-F9F0E693-F28D-4296-9A72-EBE78A0F7DB9 wds:Q37090142-FF34FFE3-C7E9-49B6-8E15-D7F2695B254E
cites work	Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases. Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Improved survival with vemurafenib in melanoma with BRAF V600E mutation Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032) Vemurafenib and radiation therapy in melanoma brain metastases Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis Challenges with the diagnosis and treatment of cerebral radiation necrosis Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436). Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis Principles of therapeutic drug monitoring.
author name string	wds:Q37090142-469F7DC6-83E0-4627-B8A5-6DCF1B2514F9 wds:Q37090142-8B3B7F99-A318-46A5-B957-141D1A50B9B0 wds:Q37090142-AB0DC975-7868-4958-A573-CF492A065AAB wds:Q37090142-B85913A9-9BA0-401B-8A7B-6AA0CDABC54E wds:Q37090142-E4F18516-7470-4DC4-8B36-DA9511204046
author name string	Ragini Kudchadkar Roshan S Prabhu Kirtesh R Patel David H Lawson Mohammad K Khan
rdfs:label	BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (en) BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (nl)
skos:prefLabel	BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (en) BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (nl)
name	BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (en) BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (nl)
author	wds:Q37090142-704443F6-5EEE-4E0B-BBD2-630B1EAFBB1C wds:Q37090142-82F2E030-D99C-4596-8313-F80C56BF4162 wds:Q37090142-EA2A06EC-A9AE-4FCA-AD21-F9661A8BD5D5
author	Richard J. Cassidy Jeffrey M Switchenko Mudit Chowdhary
title	wds:Q37090142-A4B075DA-9CA9-4F2C-9F8C-1EB7C105CAFD
title	BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis (en)
page(s)	wds:Q37090142-7D438CF8-A1C8-4885-9FB9-24B011A5E8DD
page(s)	387-394
instance of	wds:Q37090142-8221F87E-A6A2-4119-A42F-A743224DE0B0
instance of	scholarly article
PubMed ID	wds:Q37090142-F86243D3-8537-4B7B-855D-771ADFC2CB32

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software